[1]
Boyd, D.B.; Parril, A.L.; Reddy, M.R. Rational Drug Design: Novel Methodology and Practical Applications, ACS Symposium Series 719, 1999, 347-356.
[2]
Tropsha, A.; Zheng, W.; Becker, O. M.; Mackerell, A. D., Jr; Roux, B.; Watanabe, M.; Marcel, D. Computational Biochemistry and Biophysics, 2001, 351-369.
[3]
Kumar, A.; Jha, A. Drug Development Strategies; Anticandidal Agents, 2016, pp. 63-71.
[9]
Martínez, I.T. Análisis Conformacional Teórico y Síntesis dederivados 4-sutituidos-2,6- bis 4-morfolínmetil fenoles conpotencial actividad antiarrítmica Master Thesis.. 2004.
[10]
Velázquez, A. Ma.; Torres, L. A.; Díaz, G.; Ramírez, A.; Hernández, R.; Santillán, H.; Martínez, L.; Martínez, I.; Díaz-Barriga, S.; Ávrego, V.; Balboa, M. A.; Camacho, B.; López, C. R.; Dueñas-González, A.; Cabrera, G.; Ángeles, E. A novel one pot Mannich synthesis of methylpiperidin phenols, methylphenylmorfolin phenols and methyltiophenylmorpholin phenols solvent-free and using infrared light irradiation. ARKIVOC, 2006, ii, 150-161.
[11]
Martínez, L. 12º Congreso Nacional de Hipertensión Arterial, Cd. de México, 2004. V Congreso Internacional de Química e Ingeniería
QuímicaHabana
[12]
Evaluation of the inhibition of new thiomorpholin compounds and the Angiotensin Converting Enzyme through Capillary Zone Electrophoresis., 2018.
[13]
Molecular Operating Environment (MOE), 2013.08; Chemical Computing Group ULC, 1010 Sherbooke St. West, Suite #910, Montreal, QC, Canada, H3A 2R7 2018.
[14]
Frisch, M.J.; Trucks, G.W.; Schlegel, H.B.; Scuseria, G.E.; Robb, M.A.; Cheeseman, J.R.; Scalmani, G.; Barone, V.; Petersson, G.A.; Nakatsuji, H.; Li, X.; Caricato, M.; Marenich, A.V.; Bloino, J.; Janesko, B.G.; Gomperts, R.; Mennucci, B.; Hratchian, H.P.; Ortiz, J.V.; Izmaylov, A.F.; Sonnenberg, J.L.; Williams-Young, D.; Ding, F.; Lipparini, F.; Egidi, F.; Goings, J.; Peng, B.; Petrone, A.; Henderson, T.; Ranasinghe, D.; Zakrzewski, V.G.; Gao, J.; Rega, N.; Zheng, G.; Liang, W.; Hada, M.; Ehara, M.; Toyota, K.; Fukuda, R.; Hasegawa, J.; Ishida, M.; Nakajima, T.; Honda, Y.; Kitao, O.; Nakai, H.; Vreven, T.; Throssell, K. Gaussian 16, Revision B.01 2018.
[16]
Martínez, A. L.; Velázquez, S. A.; Diaz-Barriga, S.; Romero, R. A.; Posada, G.; María, E.; Ángeles, A. E. Synthesis of phenolderivative novel methyl-thiomorpholine compounds for treating cardiovascular diseases. Universidad Nacional Autónoma de México, Mex. Mex. Pat. Appl., 2012. CODEN: MXXXA3 MX 2005PA12635 A 20070522 Patent written in Spanish. Application: MX 2005-12635 20051123 Title 298633 2012.
[17]
Certara, L.P. SYBYL®-X 2.1.1 2011-2018 Molecular modeling and simulation suite, 2018.
